Study of a kindred with classic congenital adrenal hyperplasia: Diagnostic challenge due to phenotypic variance

被引:24
作者
Chin, DS
Speiser, PW
Imperato-McGinley, J
Dixit, N
Uli, N
David, R
Oberfield, SE
机构
[1] NYU Med Ctr, Dept Pediat, New York, NY 10016 USA
[2] N Shore Univ, Med Ctr, Dept Pediat, New York, NY 11030 USA
[3] Cornell Univ, Med Ctr, Dept Med, New York, NY 10021 USA
关键词
D O I
10.1210/jc.83.6.1940
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We sought to determine the concordance of the phenotype and genotype in a kindred with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency. The variation in phenotypic expression within this family underscores the difficulty of establishing the diagnosis in the absence of newborn screening, even with a heightened index of suspicion. Steroidogenic profiles were obtained for the three affected siblings. The available clinical history of the two affected aunts was retrieved. Genotyping was performed on several members of the kindred. Detailed sequencing of the entire CYP21 gene of two clinically dissimilar subjects in this family was undertaken to explore the possibility of other mutations or polymorphisms. PCR with ligase detection reaction analysis of CYP21 revealed that the affected family members III-2, III-3, III-4, II-3, and II-4, all were compound heterozygotes carrying the intron 2 point mutation known to interfere with splicing (nucleotide 656 A to G) and the exon 4 point mutation causing a nonconservative substitution of asparagine for isoleucine at codon 172 (I172N). Detailed sequencing of the gene was performed for the two most phenotypically dissimilar subjects. A single silent polymorphism was found in the third nucleotide for codon 248 in patient II-4, but not in patient III-4, and no additional mutations were found. Classic congenital adrenal hyperplasia remains a difficult diagnosis to make in the absence of newborn screening because of the variability of phenotypic expression. Likewise, the variable degree of genital ambiguity in affected females in this family serves to question universal advocacy of prenatal steroid treatment in pregnancies at risk for congenital adrenal hyperplasia. Extensive molecular exploration did not provide an explanation of the phenotypic heterogeneity and supports the possibility of influences other than the CYP21 gene for the observed divergence.
引用
收藏
页码:1940 / 1945
页数:6
相关论文
共 37 条
[1]   Improved precision of newborn screening for congenital adrenal hyperplasia using weight-adjusted criteria for 17-hydroxyprogesterone levels [J].
Allen, DB ;
Hoffman, GL ;
Fitzpatrick, P ;
Laessig, R ;
Maby, S ;
Slyper, A .
JOURNAL OF PEDIATRICS, 1997, 130 (01) :128-133
[2]  
Balsamo A, 1996, PEDIATRICS, V98, P362
[3]   CLINICAL HETEROGENEITY OF 21-HYDROXYLASE DEFICIENCY OF SIBS WITH IDENTICAL 21-HYDROXYLASE GENES [J].
BORMANN, M ;
KOCHHAN, L ;
KNORR, D ;
BIDLINGMAIER, F ;
OLEK, K .
ACTA ENDOCRINOLOGICA, 1992, 126 (01) :7-9
[4]   ANOGENITAL RATIO - MEASURE OF FETAL VIRILIZATION IN PREMATURE AND FULL-TERM NEWBORN-INFANTS [J].
CALLEGARI, C ;
EVERETT, S ;
ROSS, M ;
BRASEL, JA .
JOURNAL OF PEDIATRICS, 1987, 111 (02) :240-243
[5]   DIFFERENCE IN TRANSCRIPTIONAL ACTIVITY OF 2 HOMOLOGOUS CYP21A GENES [J].
CHANG, SF ;
CHUNG, BC .
MOLECULAR ENDOCRINOLOGY, 1995, 9 (10) :1330-1336
[6]  
DALTON K, 1981, NEUROPHARMACOLOGY, V20, P1267
[7]   Identification of non-amplifying CYP21 genes when using PCR-based diagnosis of 21-hydroxylase deficiency in congenital adrenal hyperplasia (CAH) affected pedigrees [J].
Day, DJ ;
Speiser, PW ;
Schulze, E ;
Bettendorf, M ;
Fitness, J ;
Barany, F ;
White, PC .
HUMAN MOLECULAR GENETICS, 1996, 5 (12) :2039-2048
[8]   DETECTION OF STEROID 21-HYDROXYLASE ALLELES USING GENE-SPECIFIC PCR AND A MULTIPLEXED LIGATION DETECTION REACTION [J].
DAY, DJ ;
SPEISER, PW ;
WHITE, PC ;
BARANY, F .
GENOMICS, 1995, 29 (01) :152-162
[9]   PITFALLS IN THE ETIOLOGICAL DIAGNOSIS OF CONGENITAL ADRENAL-HYPERPLASIA IN THE EARLY NEONATAL-PERIOD [J].
DEPERETTI, E ;
FOREST, MG .
HORMONE RESEARCH, 1982, 16 (01) :10-22
[10]   Growth pattern during the first 36 months of life in congenital adrenal hyperplasia (21-hydroxylase deficiency) [J].
Gasparini, N ;
DiMaio, S ;
Salerno, M ;
Argenziano, A ;
Franzese, A ;
Tenore, A .
HORMONE RESEARCH, 1997, 47 (01) :17-22